University Hospitals Case Medical Center
- Consultant: Alexza Pharmaceuticals; American Psychiatric Publishing; AstraZeneca LP; Biovail; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Guilford Press; Johnson & Johnson; KemPharm; Lundbeck; Novartis Pharmaceutical Corporation; Noven Pharmaceuticals, Inc.; Organon; Otsuka America Pharmaceuticals, Inc.; Pfizer Inc.; Physicians Postgraduate Press; Roche; Sanofi-Aventis; Schering-Plough; Seaside Therapeutics; Seprarcor Inc.; Shire Pharmaceuticals Inc.; Sunovion; Supernus Pharmaceuticals, Inc.; Transcept Pharmaceuticals, Inc.; WebMD; Wyeth
- Grant Support: Alexza Pharmaceuticals; AstraZeneca LP; Biovail; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson; Merck & Co., Inc.; National Institutes of Health; Neruopharm; Novartis Pharmaceutical Corporation; Otsuka America Pharmaceuticals, Inc.; Pfizer Inc.; Rhodes Pharmaceuticals; Schering-Plough; Shionogi Pharma, Inc.; Shire Pharmaceuticals Inc.; Stanley Medical Research Institute; Supernus Pharmaceuticals, Inc.; Wyeth
- Royalties: Alexza Pharmaceuticals; American Psychiatric Publishing; Guilford Press; Sage; The Johns Hopkins University Press
- Speakers Bureau: Shire Pharmaceuticals Inc.